BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response
about
BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response
description
im März 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2012
@en
name
BCR-ABL activity measured by 5 ...... not predict treatment response
@en
type
label
BCR-ABL activity measured by 5 ...... not predict treatment response
@en
prefLabel
BCR-ABL activity measured by 5 ...... not predict treatment response
@en
P2093
P1433
P1476
BCR-ABL activity measured by 5 ...... not predict treatment response
@en
P2093
Dana Dvorakova
Filip Razga
Irena Koutna
Jiri Mayer
Martina Peterkova
Michaela Potesilova
Pavel Simara
Tomas Jurcek
Zdenek Racil
P304
P356
10.3109/10428194.2012.656104
P50
P577
2012-03-01T00:00:00Z